{"id":"https://openalex.org/A5069050774","orcid":"https://orcid.org/0000-0002-5553-9543","observed_orcids":["https://orcid.org/0000-0002-5553-9543"],"display_name":"Pelin Tokal\u0131","raw_author_names":["Pelin Tokal\u0131","Tokal\u0131, Pelin"],"full_name":"Tokal\u0131, Pelin","works_count":15,"cited_by_count":416,"summary_stats":{"2yr_mean_citedness":22.928571428571427,"h_index":10,"i10_index":11},"ids":{"openalex":"https://openalex.org/A5069050774","orcid":"https://orcid.org/0000-0002-5553-9543","observed_orcids":["https://orcid.org/0000-0002-5553-9543"]},"affiliations":[{"institution":{"id":"https://openalex.org/I135987583","ror":"https://ror.org/04v302n28","display_name":"Kafkas University","country_code":"TR","type":"education","lineage":["https://openalex.org/I135987583"]},"years":[2026,2025,2024,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I135987583","ror":"https://ror.org/04v302n28","display_name":"Kafkas University","country_code":"TR","type":"education","lineage":["https://openalex.org/I135987583"]}],"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":15,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":6,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":5,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","count":5,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","count":5,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","value":0.0002204,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","value":0.0001312,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":4.21e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":2.96e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","value":2.12e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9682000279426575},{"id":"202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","score":0.7376109957695007},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.6658965945243835},{"id":"71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","score":0.5763000249862671},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.485486775636673}],"counts_by_year":[{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":3},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":13},{"year":2024,"works_count":1,"oa_works_count":0,"cited_by_count":34},{"year":2025,"works_count":8,"oa_works_count":0,"cited_by_count":152},{"year":2026,"works_count":5,"oa_works_count":2,"cited_by_count":214}],"display_name_alternatives":["Pelin Tokal\u0131","Tokal\u0131, Pelin"],"block_key":"p tokali","works_api_url":"https://api.openalex.org/works?filter=author.id:A5069050774","updated_date":"2026-11-07T12:08:38","created_date":"2022-09-14T00:00:00"}